Background illustration for clinical trials search

Paid Clinical Trials Irvine

Discover 3,580 paid clinical trials in Irvine, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

for
Schizophrenia
Location: Los Alamitos CA, Austin TX, Chicago IL, Atlanta GA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18 - 55

Code: NCT07061288

Phase1, Recruiting

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

for
Metastatic Castration-resistant Prostatic Neoplasms
Location: Los Angeles CA, La Jolla CA, San Francisco CA,
Sponsor: Janssen Research & Development, LLC

Sex: Male

Age: 18+

Code: NCT07164443

Phase3, Recruiting

NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

for
Schizophrenia
Location: Riverside CA, Culver City CA, Garden Grove CA,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18 - 65

Code: NCT07105098

Phase3, Recruiting

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

for
Prostate Cancer Metastatic
Location: Riverside CA, Las Vegas NV, Palo Alto CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136624

Phase3, Recruiting

A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Adult Participants With Bipolar Disorder

for
Bipolar Disorder
Location: Los Alamitos CA
Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT07071532

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

for
Metastatic Cancer, Neoplasm, Prostate, Castrate-sensitive,
Location: Los Angeles CA, Portland OR, Seattle WA, Houston TX,
Sponsor: Sun Pharmaceutical Industries Limited

Sex: Male

Age: 18+

Code: NCT05422911

Phase2, Recruiting

Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)

for
ARB, BVMD, Autosomal-Dominant Bestrophinopathy,
Location: Los Angeles CA, Dallas TX, Cincinnati OH
Sponsor: Opus Genetics, Inc

Sex: All

Age: 18+

Code: NCT07185256

Phase1, Phase2, Recruiting

Single and Multiple Ascending Doses of NTX-253 in Healthy Participants and Participants With Stable Schizophrenia

for
Healthy Participants, Schizophrenia Diagnosis
Location: Los Alamitos CA
Sponsor: Neurosterix

Sex: All

Age: 18 - 55

Code: NCT07344948

Early_phase1, Recruiting

A Study of GNTI-122 in Adults Recently Diagnosed With T1D

for
Type 1 Diabetes (T1D), Type 1 Diabetes Mellitus
Location: Duarte CA, San Diego CA, San Francisco CA,
Sponsor: GentiBio, Inc

Sex: All

Age: 18 - 55

Code: NCT06919354

Phase1, Recruiting

A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia

for
Schizophrenia
Location: Los Alamitos CA, Richardson TX, Little Rock AR,
Sponsor: Leal Therapeutics, Inc

Sex: All

Age: 18 - 55

Code: NCT07734493

Phase1, Recruiting

EXoPERT EMERALD Clinical Study

for
Breast Cancer, Colon Cancer, Pancreatic Cancer, Ovarian Cancer,
Location: Long Beach CA, Los Angeles CA, Louisville KY,
Sponsor: EXoPERT

Sex: All

Age: 45+

Code: NCT07186296

Recruiting

Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)

for
Gastrointestinal Cancer, Gastric Cancer, Esophageal Cancer,
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center

Sex: All

Age: 18+

Code: NCT07124351

Recruiting

Early Feasibility Study (EFS) Evaluating Percutaneous Repair of the Atrial Septum With a Novel PFO Occluder: The PROTEA-PFO Study

for
PFO, PFO - Patent Foramen Ovale, Cryptogenic Stroke,
Location: Los Angeles CA, Greenville SC, Gainsville FL,
Sponsor: Recross Cardio, Inc.

Sex: All

Age: 18 - 65

Code: NCT07172464

Recruiting

Neoadjuvant Darovasertib in Primary Uveal Melanoma

for
Uveal Melanoma
Location: Riverside CA, Scottsdale AZ, Palo Alto CA, Aurora CO,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT07015190

Phase3, Recruiting

A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)

for
Alzheimer Disease, Healthy
Location: Los Alamitos CA, Atlanta GA, Decatur GA, Lady Lake FL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 45 - 70+

Code: NCT06657768

Phase1, Recruiting

A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease

for
Parkinson Disease
Location: Los Alamitos CA, Austin TX, Farmington Hills MI,
Sponsor: Eli Lilly and Company

Sex: All

Age: 30 - 70+

Code: NCT06809400

Phase1, Recruiting
New

Study to Assess Safety and Tolerability of KarXT With Administration of Antiemetics in Healthy Volunteers

for
Healthy Volunteers
Location: Los Alamitos CA, Atlanta GA, Decatur GA, Hollywood FL
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Sex: All

Age: 18 - 65

Code: NCT07681076

Recruiting

Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer

for
Localized Clear Cell Renal Cell Carcinoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07226544

Phase2, Recruiting

A Study to Evaluate the Effect of Food on the Bioavailability of AJ201, and Safety, Tolerability, and Pharmacokinetics of AJ201 in Japanese and White Healthy Male Participants

for
Healthy Male Adults, Food Effect in Healthy Volunteers
Location: Los Alamitos CA
Sponsor: AnnJi Pharmaceutical Co., Ltd.

Sex: Male

Age: 18 - 55

Code: NCT07549919

Phase1, Recruiting

Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma

for
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Irvine CA, Duarte CA, Pittsburgh PA
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07156227

Phase1, Recruiting